Related references
Note: Only part of the references are listed.High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication
Kenta Takahashi et al.
PLoS Pathogens (2020)
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Luc Van Kaer et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview
Eliane Piket et al.
JOURNAL OF AUTOIMMUNITY (2019)
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
Nina Boxberger et al.
JOURNAL OF IMMUNOLOGY (2019)
MicroRNA expression studies: challenge of selecting reliable reference controls for data normalization
Soheil Madadi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Impact of B cells to the pathophysiology of multiple sclerosis
Borros M. Arneth
JOURNAL OF NEUROINFLAMMATION (2019)
A review of the evidence for a natalizumab exit strategy for patients with multiple sclerosis
Johann Sellner et al.
AUTOIMMUNITY REVIEWS (2019)
miR-191 modulates B-cell development and targets transcription factors E2A, Foxp1, and Egr1
Jonas Blume et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Characterization of blood-brain barrier integrity in a B-cell-dependent mouse model of multiple sclerosis
Luisa Bell et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2019)
Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis
Anuj et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications
Jessy A. Slota et al.
NON-CODING RNA (2019)
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease
Maria Liguori et al.
HUMAN MOLECULAR GENETICS (2018)
Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells
Ying Cui et al.
ONCOLOGY LETTERS (2018)
Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis
Sanam Dolati et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Let-7 Suppresses B Cell Activation through Restricting the Availability of Necessary Nutrients
Shuai Jiang et al.
CELL METABOLISM (2018)
Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma
Chen Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination
Iana H. Haralambieva et al.
PLOS ONE (2018)
miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R
Na Liu et al.
ONCOTARGETS AND THERAPY (2018)
MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice
Yuan Xia et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
The Function of MicroRNAs in B-Cell Development, Lymphoma, and Their Potential in Clinical Practice
Bing Zheng et al.
FRONTIERS IN IMMUNOLOGY (2018)
Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis
Camille A. Juzwik et al.
SCIENTIFIC REPORTS (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis
David Bargiela et al.
NEUROLOGY (2017)
The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
Barry A. Singer
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2017)
Exosomal microRNA signatures in multiple sclerosis reflect disease status
Saeideh Ebrahimkhani et al.
SCIENTIFIC REPORTS (2017)
MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer
Ke Wei et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy
Dhanashri P. Miskin et al.
JOURNAL OF NEUROVIROLOGY (2016)
The role of microRNAs in the pathogenesis of autoimmune diseases
Ji-Qing Chen et al.
AUTOIMMUNITY REVIEWS (2016)
MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb (vol 131, pg 146, 2007)
Changchun Xiao et al.
CELL (2016)
Regulation of B-cell development and tolerance by different members of the miR-17 ∼ 92 family microRNAs
Maoyi Lai et al.
NATURE COMMUNICATIONS (2016)
Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review
Magdalena J. Kacperska et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
Petra Bergman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a
Latt Latt Aung et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
miR-15b/16-2 deletion promotes B-cell malignancies
Francesca Lovat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b
Jens Ingwersen et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis
Xinting Ma et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
Yusei Miyazaki et al.
PLOS ONE (2014)
MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)
Weidong Zhou et al.
CELL AND BIOSCIENCE (2014)
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders
Anu Kauppinen et al.
CELLULAR SIGNALLING (2013)
MicroRNAs and multiple sclerosis: from physiopathology toward therapy
Ameneh Zare-Shahabadi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis
Arie Reijerkerk et al.
JOURNAL OF NEUROSCIENCE (2013)
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section
Joseph R. Berger et al.
NEUROLOGY (2013)
MicroRNA regulation of integrins
Weiguo Chen et al.
TRANSLATIONAL RESEARCH (2013)
Altered microRNA expression in B lymphocytes in multiple sclerosis Towards a better understanding of treatment effects
Claudia Sievers et al.
CLINICAL IMMUNOLOGY (2012)
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain
Michael W. Ferenczy et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Network Analysis of Randomized Controlled Trials in Multiple Sclerosis
Elias Zintzaras et al.
CLINICAL THERAPEUTICS (2012)
Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells
Michael R. Epis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Markus C. Kowarik et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis
Luca Prosperini et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes
Yi-Bing Ouyang et al.
MITOCHONDRION (2012)
Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus
Yao Yuan et al.
MOLECULAR IMMUNOLOGY (2012)
Regulated microRNAs in the CSF of patients with multiple sclerosis A case-control study
Aiden Haghikia et al.
NEUROLOGY (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Virus-Encoded microRNAs: An Overview and a Look to the Future
Rodney P. Kincaid et al.
PLOS PATHOGENS (2012)
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
Ludwig Kappos et al.
LANCET NEUROLOGY (2011)
B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset
Catalina Lee-Chang et al.
NEUROSCIENCE LETTERS (2011)
Functional delivery of viral miRNAs via exosomes
D. Michiel Pegtel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls
Andreas Keller et al.
PLOS ONE (2009)
The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies
Michael K. Racke
CURRENT OPINION IN NEUROLOGY (2008)
Evolutionarily Conserved Function of a Viral MicroRNA
G. J. Seo et al.
JOURNAL OF VIROLOGY (2008)
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181
Yuri Pekarsky et al.
CANCER RESEARCH (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)